De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes undergoing anti-HER2 targeted therapy
BackgroundIn the era of anti-HER2 targeted therapy, the potential clinical feasibility of considering HER2-overexpressing breast cancer cases presenting with 1-3 positive axillary lymph nodes as low-risk, and thereby contemplating postoperative radiotherapy reduction, remains an important subject fo...
Main Authors: | Jing Liu, Suning Huang, Zhuofei Bi, Xiaoxue Zhang, Ziqing He, Xiaowen Lan, Yuting Tan, Xiao Lin, Wenyi Zhou, Xiaobo Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1280900/full |
Similar Items
-
Factors Influencing Lymph Node Positivity in HER2/neu+ Breast Cancer Patients
by: Katherine Englander, et al.
Published: (2023-02-01) -
HER2-low metastases of HER2-negative primary tumors: a single institution analysis of intertumoral and internodal heterogeneity in node-positive breast cancer
by: Ulrika Pellas, et al.
Published: (2023-07-01) -
Prognostic analysis of the patients with HER2-positive breast cancer adjuvant treated with trastuzumab: a report of 1 246 cases
by: LI Yuefeng, HONG Jin, LI Zhian, RUAN Guodong, CHEN Weiguo
Published: (2023-09-01) -
Pattern of HER2 Overexpression in Urinary Bladder Carcinomas in Kano, Nigeria
by: Muhammad Sanusi Haruna, et al.
Published: (2023-01-01) -
The clinical value of Delphian and pre-tracheal lymph nodes in predicting lateral lymph nodes metastasis of papillary thyroid carcinoma
by: Chun Huang, et al.
Published: (2025-12-01)